Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 8, 2025Expert Review of Pharmacoeconomics & Outcomes Research

Present challenges impacting the management of psychological symptoms in patients receiving CAR-T therapy or stem cell transplantation

View Full Paper
Ask AI
Bookmark
Share

Authors

AFAihan FengMGMadhuri GottamWSWil L. Santivasi

Discussion

Loading...

Member takes

Overview

Observational analysis highlights psychological symptoms in patients receiving CAR-T therapy and HSCT, suggesting a need for targeted support.

Key Points

  • Psychological symptoms are prevalent among patients undergoing CAR-T therapy, impacting their treatment experience.
  • Emerging findings indicate that both HSCT and CAR-T therapies pose unique psychological challenges for patients.
  • Assessment of psychological well-being during HSCT and CAR-T therapy reveals significant patient stressors.
  • Effective management of psychological symptoms is critical to enhancing overall patient outcomes in hematologic malignancies.

Cite This Study

Feng et al. (2025) studied this question.

synapsesocial.com/papers/68e6d7971ffa7aa7d63d18dfhttps://doi.org/10.1080/14737167.2025.2572317
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1CAR-T cell Therapy; Toxicities and Current aspects of Management2025
  2. 2Challenges in the preclinical design and assessment of CAR-T cells2025
  3. 3OUT COMES AFTER CAR T CELL THERAPY IN THE LONG RUN2025
  4. 4The new era of immunotherapy for breast cancer: challenges and coping strategies of CAR-T cell therapy2025
  5. 5Major Adverse Events with Chimeric Antigen Receptor T-Cell Therapy: Presentation, Diagnosis, and Resuscitation2025